Expression of Aurora kinases A and B in normal, hyperplastic, and malignant human endometrium: Aurora B as a predictor for poor prognosis in endometrial carcinoma

• DOI: 10.1016/j.humpath.2005.09.014
• Publication Date: 2005-11-29T12:42:00Z
• Authors: Miyuki Kurai; Tanri Shiozawa; Hsien-Chang Shih; Tsutomu Miyamoto; Yu-Zhen Feng; Hiroyasu Kashima; Akihisa Suzuki; Ikuo Konishi
• Keywords: Adult; 0301 basic medicine; Blotting, Western; Adenocarcinoma; Middle Aged; Protein Serine-Threonine Kinases; Endometrial Neoplasms; 3. Good health; Gene Expression Regulation, Neoplastic; Endometrium; 03 medical and health sciences; Ki-67 Antigen; Aurora Kinases; Endometrial Hyperplasia; Biomarkers, Tumor; Carcinoma, Squamous Cell; Aurora Kinase B; Humans; Female; RNA, Messenger; Aged; Cell Proliferation; Neoplasm Staging

Aurora kinases such as Aurora A and Aurora B are key regulators of mitosis and have been reported to be overexpressed in various malignancies. However, the expression and localization of Aurora kinases in normal and neoplastic endometrial tissues remain undetermined. In the present study, immunohistochemical expression of Aurora A and B was examined in 40 normal, 30 hyperplastic, and 73 malignant endometria. The data were compared with the expression of Ki-67 and patient survivals. The expression of Aurora A and B at protein and messenger RNA levels was also examined using Western blotting and the reverse transcriptase polymerase chain reaction. The expression of Aurora A in normal endometrium was observed mainly in the proliferative phase and was decreased in the secretory phase. The Aurora A expression was significantly increased in carcinomas compared with normal proliferative endometrium; however, there was no correlation of Aurora A expression with Ki-67 expression or patient survival. The expression of Aurora B in normal endometrium was significantly higher in the proliferative phase than in the secretory phase. In endometrial carcinomas, the expression of Aurora B was correlated with Ki-67 expression and was significantly increased in high-grade tumors. In addition, patients with Aurora B-positive carcinoma showed poor prognosis compared with those with Aurora B-negative carcinoma (P = .0135). Accordingly, the present study indicates the aberrant expression of Aurora A and Aurora B in endometrial carcinomas and the clinical importance of Aurora B expression in relationship to patient prognosis.